Robert Charles Jahr - 01 Jul 2025 Form 4 Insider Report for Outlook Therapeutics, Inc. (OTLK)

Role: Chief Executive Officer
Signature: /s/ Robert Jahr
Issuer symbol: OTLK
Transactions as of: 01 Jul 2025
Net transactions value: $0
Form type: 4
Filing time: 09 Jul 2025, 17:17:49 UTC
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Jahr Robert Charles	Chief Executive Officer	C/O OUTLOOK THERAPEUTICS, INC., 111 SOUTH WOOD AVENUE, UNIT #100, ISELIN	/s/ Robert Jahr	09 Jul 2025	0002076177

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	OTLK	Stock Option (Right to Buy)	Award	$0	+800,000		$0.000000	800,000	01 Jul 2025	Common Stock	800,000	$1.58	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	25% of the shares subject to the option will vest on July 1, 2026, with the remaining shares vesting in 36 equal monthly installments over the following three (3) years, subject to the Reporting Person's Continuous Service to the Issuer through each such vesting date.